Literature DB >> 6600618

T lymphocyte subsets in the peripheral blood of patients with benign and malignant breast disease.

D R McCluskey, A D Roy, W P Abram, W M Martin.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6600618      PMCID： PMC2011294          DOI： 10.1038/bjc.1983.41

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  10 in total

1.  Decreased T-lymphocytes in patients with mammary cancer.

Authors:  S E Keller; H L Ioachim; T Pearse; D M Siletti
Journal:  Am J Clin Pathol       Date:  1976-04       Impact factor: 2.493

2.  Relationship between T lymphocyte levels and lymphoproliferative responses to mitogens and alloantigens in lung and breast cancer patients.

Authors:  T R Jerrells; J H Dean; R B Herberman
Journal:  Int J Cancer       Date:  1978-03-15       Impact factor: 7.396

3.  Monoclonal antibodies defining distinctive human T cell surface antigens.

Authors:  P Kung; G Goldstein; E L Reinherz; S F Schlossman
Journal:  Science       Date:  1979-10-19       Impact factor: 47.728

4.  Cellular immunity in early human breast carcinoma.

Authors:  L C Conesa; R S Pasqualini; D Pujato; M Lynch
Journal:  Cell Mol Biol Incl Cyto Enzymol       Date:  1979

5.  Immunological studies in breast cancer lymphoid populations.

Authors:  C Cervantes; G Exposito; L Moreno; M E Garcia
Journal:  Neoplasma       Date:  1979       Impact factor: 2.575

6.  Depressed lymphocyte function in carcinoma of the breast.

Authors:  M G Whittaker; C G Clark
Journal:  Br J Surg       Date:  1971-10       Impact factor: 6.939

7.  Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells.

Authors:  M Zembala; B Mytar; T Popiela; G L Asherson
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

8.  Monoclonal anti-human T-lymphocyte antibodies: enumeration and characterization of T-cell subsets.

Authors:  J Van Wauwe; J Goossens
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

9.  Modern approaches to the treatment of breast cancer.

Authors:  C K Osborne; W A Knight; M G Yochmowitz; W L McGuire
Journal:  Blood       Date:  1980-11       Impact factor: 22.113

10.  Immunological profile of breast cancer patients in early or advanced disease.

Authors:  E Menconi; A Barzi; M Greco; M C Caprino; L De Vecchis; F Muggia
Journal:  Experientia       Date:  1979-06-15
  10 in total
  10 in total

Review 1.  IFN-γ: A cytokine at the right time, is in the right place.

Authors:  J Daniel Burke; Howard A Young
Journal:  Semin Immunol       Date:  2019-06-17       Impact factor: 11.130

2.  Predictive value of T-cell subset derangements in lung cancer.

Authors:  C Zabbe; J D Dewitte; P Lozach; J Clavier; P Youinou
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

3.  Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas.

Authors:  T L Whiteside; S Miescher; J Hurlimann; L Moretta; V von Fliedner
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  A study of lymphocyte kinetics in nasopharyngeal carcinoma with indium III oxine-labelled lymphocytes.

Authors:  P N Cheng; W C Shiu; J O Leung; S K Ho; K K Wong; C Metreweli
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

5.  Peripheral blood and tumor-infiltrating mononuclear cell analysis in esophagus and head and neck cancer.

Authors:  P Lozac'h; P Corbeau; C Zabbe; J F Charles; P Youinou
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

6.  Splenectomy before tumor inoculation prolongs the survival time of cachectic mice.

Authors:  K Soda; M Kawakami; S Takagi; A Kashii; M Miyata
Journal:  Cancer Immunol Immunother       Date:  1995-10       Impact factor: 6.968

7.  The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers.

Authors:  C R Sheard; F Reilly; D E Tee; D Vergani; D Lowe; M Baum; A E Cameron
Journal:  Br J Cancer       Date:  1986-10       Impact factor: 7.640

8.  The effects of EPA and DHA enriched fish oil on nutritional and immunological markers of treatment naïve breast cancer patients: a randomized double-blind controlled trial.

Authors:  Elemárcia Martins da Silva Paixão; Ana Carolina de M Oliveira; Nathalia Pizato; Maria Imaculada Muniz-Junqueira; Kelly G Magalhães; Eduardo Yoshio Nakano; Marina K Ito
Journal:  Nutr J       Date:  2017-10-23       Impact factor: 3.271

9.  Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes.

Authors:  A Ferguson; M Moore; H Fox
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

10.  Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.

Authors:  H L Whitwell; H P Hughes; M Moore; A Ahmed
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.